Respiratory Syncytial Virus Disease Burden and Nirsevimab Effectiveness in Young Children From 2023-2024
医学
儿科
流行病学
人口
环境卫生
内科学
作者
Heidi L. Moline,Ariana P. Toepfer,Ayzsa Tannis,Geoffrey A. Weinberg,Mary Allen Staat,Natasha Halasa,Julie A. Boom,Eileen J. Klein,John V. Williams,Jennifer E. Schuster,Leah Goldstein,Erin R. McKeever,Casey Kalman,Clinton R. Paden,Lydia J. Atherton,Megha Aggarwal,Pavitra Roychoudhury,Pedro A. Piedra,Leila C. Sahni,Laura S Stewart
出处
期刊：JAMA Pediatrics [American Medical Association] 日期：2024-12-09卷期号：179 (2): 179-179被引量：44
This analysis documented the continued high burden of medically attended RSV-associated ARI among young children in the US. There is a potential for substantial public health impact with increased and equitable prevention product coverage in future seasons.
PDF的下载单位、IP信息已删除
(2025-6-4)
大力的灵雁
浮游
学术文献互助
Alexa
GingerF
rocio
贪玩的秋柔
vezenan
冷静的半梦
ok
无极微光
忧心的曼凝
怕黑水蓝
XiaoLiu
行者
Criminology34
ding
竹筏过海
香蕉谷芹
执着的怜珊
皖公网安备34019202002308
